Listen Now

Topics Covered

  • Overview of Mesothelioma, in the Context of COVID-19
  • Innovative Multi-Modality Treatment Options, including Chemotherapy, Surgery, Immunotherapy, Targeted Treatments, Radiation & Tumor Treating Fields
  • The Role of Clinical Trials
  • How Research Increases Treatment Options
  • Managing Side Effects, Symptoms, Discomfort & Pain
  • Communicating with Your Health Care Team about Quality-of-Life & Lifestyle Concerns
  • The Increasing Role of Telehealth/Telemedicine Appointments
  • Guidelines for Preparing for Telehealth/Telemedicine Appointments, including Technology, List of Questions & OpenNotes Discussion
  • Questions for Our Panel of Experts

Our Panel of Experts

Richard J. Gralla, MD, FACP

Professor of Medicine, Albert Einstein College of Medicine, Jacobi Medical Center

Hedy Lee Kindler, MD

Professor of Medicine Director, Mesothelioma Program, The University of Chicago Medicine

Robert Taylor Ripley, MD

Director, Mesothelioma Treatment Center, Baylor St. Luke’s Medical Center, Associate Professor of Surgery, Division of General Thoracic Surgery, Baylor College of Medicine, Member, Baylor College of Medicine, Dan L Duncan Comprehensive Cancer Center

Elizabeth K. O’Donnell, MD

Director, Lifestyle Clinic, Massachusetts General Hospital, Associate Director, Mass General Cancer Center’s Survivorship Program, Assistant Professor of Medicine, Harvard Medical School

Mary Hesdorffer, NP

Executive Director, Mesothelioma Applied Research Foundation

Carolyn Messner, DSW, OSW-C, FAPOS, FAOSW

Director of Education and Training, CancerCare

Brochure

You can download the brochure for this workshop(pdf)(118 KB)

Workshop Date

This workshop was originally recorded on September 20, 2021.

Browse by Diagnosis

Browse by Topic

The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top
Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.